Reducing risk in health-care teams: an overview

By Kavanagh Sean   Cowan Jane  

Clinical Governance: An International Journal, Vol. 9, Iss. 3, 2004-03 ,pp. : 200-204

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease

By Fischer M.   Carlone G.M.   Holst J.   Williams D.   Stephens D.S.   Perkins B.A.  

Vaccine, Vol. 17, Iss. 19, 1999-05 ,pp. : 2377-2383

Elsevier

Access to resources Recommend Favorite

Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States

By Lingappa J.R.   Rosenstein N.   Zell E.R.   Shutt K.A.   Schuchat A.   Perkins B.A.   Active Bacterial Core Surveillance ABCs Team  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4566-4575

Elsevier

Access to resources Recommend Favorite

Primary Care Clinic-Based Chronic Disease Care: Features of Successful Programs

By O'Connor P.J.  

Disease Management & Health Outcomes, Vol. 9, Iss. 12, 2001-01 ,pp. : 691-698

Adis International

Access to resources Recommend Favorite

Vaccine prevention of meningococcal disease, coming soon?

By Morley S.L.   Pollard A.J.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 666-687

Elsevier

Access to resources Recommend Favorite